๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Molecular targets for liver cancer therapy: From screening of target genes to clinical trials

โœ Scribed by Yutaka Midorikawa; Yasuyuki Sugiyama; Hiroyuki Aburatani

Book ID
118088206
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
228 KB
Volume
40
Category
Article
ISSN
1386-6346

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Clinical trials and future potential of
Clinical trials and future potential of targeted therapy for ovarian cancer
โœ Itamochi, Hiroaki; Kigawa, Junzo ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› Springer ๐ŸŒ English โš– 274 KB

Ovarian cancer is the leading cause of death in women with gynecological cancer. Most patients are diagnosed at an advanced stage with a poor prognosis. Currently, surgical tumor debulking followed by chemotherapy based on platinum and taxane is the standard treatment for advanced disease. However,

Target molecules for anti-angiogenic the
Target molecules for anti-angiogenic therapy: from basic research to clinical trials
โœ Martin Hagedorn; Andreas Bikfalvi ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 280 KB

There is growing evidence that anti-angiogenic drugs will improve future therapies of diseases like cancer, rheumatoid arthritis and ocular neovascularisation. However, it is still uncertain which kind of substance, out of the large number of angiogenesis inhibitors, will prove to be a suitable agen